Sartorius Stedim Biotech SA / Key word (s): Quarter Results/Forecast Sartorius Stedim Biotech publishes unaudited first quarter results for 2025 16-Apr-2025 / 07:00 CET/CEST ...

Choose from Biotechnology Icon stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection Essentials ...

Find Biotech Icons stock video, 4K footage, and other HD footage from iStock. Get higher quality Biotech Icons content, for less—All of our 4K video clips are the same price as HD. Video Back Videos ...

We purchased shares of Icon in March 2024 for ~$323.00 per share. Why did we sell our ICLR position and move on? Click here ...

Directives from President Donald Trump's administration to freeze grant funding from the National Institutes of Health may ...

Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on PRTG: Disclaimer & Disclosure Report an Issue Portage Biotech NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

GreensKeeper Asset Management, an investment management company, released its first quarter 2025 investor letter. A copy of ...

Fintel reports that on April 14, 2025, TD Cowen downgraded their outlook for ICON Public Limited (NasdaqGS:ICLR) from Buy to Hold. Analyst Price Forecast Suggests 68.84% Upside As of April 2, 2025, ...

Around 42 lakh students from 8,000 schools in India and abroad are appearing for the Class 10 and 12 board exams this year.